Cargando…

Etanercept Suppresses Arteritis in a Murine Model of Kawasaki Disease: A Comparative Study Involving Different Biological Agents

Coronary arteritis, a complication of Kawasaki disease (KD), can be refractory to immunoglobulin (IVIG) treatment. To determine the most effective alternative therapy, we compared the efficacy of different agents in a mouse model of KD. Vasculitis was induced by injection of Candida albicans water-s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohashi, Ryuji, Fukazawa, Ryuji, Watanabe, Makoto, Tajima, Hanako, Nagi-Miura, Noriko, Ohno, Naohito, Tsuchiya, Shinichi, Fukuda, Yuh, Ogawa, Shunichi, Itoh, Yasuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626397/ https://www.ncbi.nlm.nih.gov/pubmed/23606968 http://dx.doi.org/10.1155/2013/543141

Ejemplares similares

Kawasaki Disease-like Vasculitis Facilitates Atherosclerosis, and Statin Shows a Significant Antiatherosclerosis and Anti-Inflammatory Effect in a Kawasaki Disease Model Mouse
por: Motoji, Yusuke, et al.
Publicado: (2022)

Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease
por: Takahashi, Kei, et al.
Publicado: (2011)

Prognosis of Coronary Artery Bypass Grafting in Preschool-Aged Patients with Myocardial Ischemia Due to Giant Aneurysm of Kawasaki Disease
por: Watanabe, Makoto, et al.
Publicado: (2022)

Statins Show Anti-Atherosclerotic Effects by Improving Endothelial Cell Function in a Kawasaki Disease-like Vasculitis Mouse Model
por: Motoji, Yusuke, et al.
Publicado: (2022)

Peripheral Coronary Artery Circulatory Dysfunction in Remote Stage Kawasaki Disease Patients Detected by Adenosine Stress (13)N-Ammonia Myocardial Perfusion Positron Emission Tomography
por: Tsuno, Kanae, et al.
Publicado: (2022)

Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease
por: Ito, Fuyu, et al.
Publicado: (2022)

A Model of Left Ventricular Dysfunction Complicated by CAWS Arteritis in DBA/2 Mice
por: Hirata, Naoto, et al.
Publicado: (2012)

The involvement of the vasa vasorum in the development of vasculitis in animal model of Kawasaki disease
por: Hamaoka-Okamoto, Akiko, et al.
Publicado: (2014)

Adeno-associated Virus Vector-mediated Interleukin-10 Induction Prevents Vascular Inflammation in a Murine Model of Kawasaki Disease
por: Nakamura, Jun, et al.
Publicado: (2018)

Neutrophil activation and arteritis induced by C. albicans water-soluble mannoprotein-β-glucan complex (CAWS)
por: Ishida-Okawara, Akiko, et al.
Publicado: (2007)

The transcriptional profile of coronary arteritis in Kawasaki disease
por: Rowley, Anne H., et al.
Publicado: (2015)

CAWS administration increases the expression of interferon γ and complement factors that lead to severe vasculitis in DBA/2 mice
por: Nagi-Miura, Noriko, et al.
Publicado: (2013)

Acute renal failure as the presenting sign of disseminated intravascular coagulation in a patient with metastatic prostate cancer
por: Ohashi, Ryuji, et al.
Publicado: (2013)

Ficolin-1 is a promising therapeutic target for autoimmune diseases
por: Katayama, Michihito, et al.
Publicado: (2018)

Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression
por: Kato, Taichi, et al.
Publicado: (2023)

Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study
por: Yoshikane, Yukako, et al.
Publicado: (2021)

Variations in ORAI1 Gene Associated with Kawasaki Disease
por: Onouchi, Yoshihiro, et al.
Publicado: (2016)

Cardiovascular Involvement in Kawasaki Disease Is Much More Than Mere Coronary Arteritis
por: Pilania, Rakesh Kumar, et al.
Publicado: (2020)

Surgical Treatment of Rare Sclerosing Polycystic Adenosis of the Deep Parotid Gland
por: Matsumoto, Noriko Muto, et al.
Publicado: (2016)

Coronary artery aneurysms in children is not always Kawasaki disease: a case report on Takayasu arteritis
por: Lee, Michelle, et al.
Publicado: (2021)

The Effect of Enzymatically Polymerised Polyphenols on CD4 Binding and Cytokine Production in Murine Splenocytes
por: Yamanaka, Daisuke, et al.
Publicado: (2012)

Etanercept biosimilars
por: Azevedo, Valderilio F., et al.
Publicado: (2014)

A Case of Axillary Fibroadenoma That Grew Rapidly from Axillary Accessory Breast Tissue over 40 Days
por: Ishiguro, Akira, et al.
Publicado: (2023)

Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study
por: Nanishi, Etsuro, et al.
Publicado: (2017)

Thyroid Hürthle Cell Carcinoma: Clinical, Pathological, and Molecular Features
por: Kure, Shoko, et al.
Publicado: (2020)

Augmented TLR2 Expression on Monocytes in both Human Kawasaki Disease and a Mouse Model of Coronary Arteritis
por: Lin, I-Chun, et al.
Publicado: (2012)

Treatment of LADA With Etanercept
por: Montes, Vince N., et al.
Publicado: (2012)

Etanercept-associated myelitis
por: Finke, Carsten, et al.
Publicado: (2015)

Etanercept-associated Nephropathy
por: Ammar, Awais, et al.
Publicado: (2019)

Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022)

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
por: Felis-Giemza, Anna, et al.
Publicado: (2019)

Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Mercury increases IL-1β and IL-18 secretion and intensifies coronary arteritis in an animal model of Kawasaki disease
por: Alphonse, Martin P., et al.
Publicado: (2023)

Complete Genome Sequence of Streptococcus mitis Strain Nm-65, Isolated from a Patient with Kawasaki Disease
por: Tabata, Atsushi, et al.
Publicado: (2021)

Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials
por: Takeuchi, Tsutomu, et al.
Publicado: (2015)

Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis
por: Miyabe, Chie, et al.
Publicado: (2019)

Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007)

Etanercept in the treatment of plaque psoriasis
por: Nguyen, Thao U, et al.
Publicado: (2009)

Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)

GP2015: An Etanercept Biosimilar
por: Deeks, Emma D.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5a2s5fjsqo2er2ojmujk882o8g